Analysis of the serological response to Chlamydia pneumoniae in patients with ischemic heart disease by recombinant MOMP-ELISA

Journal of Infection and Chemotherapy

Volumn 7, Issue 3, 2001, Pages 180-185

  Kido, Y ^a   Shirai, M ^a   Ouchi, K ^b   Nakazawa, T ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Saiseikai Shimonoseki General Hospital   (Japan)

Author keywords

Chlamydia pneumoniae; Coronary heart disease; ELISA; Recombinant MOMP

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; OUTER MEMBRANE PROTEIN; RECOMBINANT PROTEIN; THIOREDOXIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; PROTEIN PURIFICATION; SEROLOGY;

EID: 0034761473     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101560100032     Document Type: Article

References (30)

1. Identification of a new group of Chlamydia psittaci strains called TWAR
2. Chlamydia pneumoniae sp. nov. for Chlamydia sp. strain TWAR
3. Prevalence of antibody to Chlamydia pneumoniae TWAR in Japan
4. Chlamydia pneumoniae (TWAR)
5. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors
6. Review of Chlamydia pneumoniae and atherosclerosis
7. Pathogenesis of atherosclerosis: A possible relation to infection
8. Chlamydia pneumoniae in coronary and iliac arteries of Japanese patients with atherosclerotic cardiovascular diseases
9. Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study
10. Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans
11. Antigenic and molecular analyses of different Chlamydia pneumoniae strains
12. Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile
13. Serological response to Chlamydia pneumoniae in patients with sarcoidosis
14. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques
15. Analysis of the humoral immune response to Chlamydia outer membrane protein 2
16. Immunore-activity of the 60kDa cysteine-rich proteins of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae expressed in Escherichia coli
17. Isolation and characterization of a gene encoding a Chlamydia pneumoniae 76-kilodalton protein containing a species-specific epitope
18. Sequence analysis of the major outer membrane protein gene of Chlamydia pneumoniae
19. Serological response to Chlamydia pneumoniae infection
20. Lymphotoxin inhibits Chlamydia pneumoniae growth in HEp-2 cells
21. Formalinized Chlamydia trachomatis organisms as antigen in the micro-immunofluorescence test
22. Cleavage of structural proteins during the assembly of the head of bacteriophages T4
23. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm
24. Highly sensitive and specific enzyme-linked immunosorbent assays for GAD65 autoantibodies using a thioredoxin-GAD65 fusion antigen
25. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method 1. Evaluation of ELISA kit using outer membrane complex
26. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease
27. Association of chronic infection of Chlamydia pneumoniae and coronary heart disease in the Japanese
28. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart study
29. Association of chlamydial infection with cerebrovascular disease